Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A

被引：128

作者：

Astermark, J. ^{[1
]}

Wang, X.

Oldenburg, J.

Berntorp, E.

Lefvert, A. -K.

机构：

[1] Malmo Univ Hosp, Dept Coagulat Disorders, Malmo, Sweden

[2] Karolinska Inst, Ctr Mol Med, Immunol Res Lab, Stockholm, Sweden

[3] Karolinska Inst, Dept Med, Stockholm, Sweden

[4] Univ Clin Bonn, Inst Expt Haematol & Transfus Med, Bonn, Germany

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2007年 / 5卷 / 02期

关键词：

D O I：

10.1111/j.1538-7836.2007.02290.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：263 / 265

页数：3

共 15 条

[1] Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population [J].

Ahmed, S ;

Ihara, K ;

Kanemitsu, S ;

Nakashima, H ;

Otsuka, T ;

Tsuzaka, K ;

Takeuchi, T ;

Hara, T .

RHEUMATOLOGY, 2001, 40 (06) :662-667

[2] Why do inhibitors develop? Principles of and factors influencing the risk for inhibitor development in haemophilia [J].

Astermark, J .

HAEMOPHILIA, 2006, 12 :52-60

[3] Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A [J].

Astermark, J ;

Oldenburg, J ;

Pavlova, A ;

Berntorp, E ;

Lefvert, AK .

BLOOD, 2006, 107 (08) :3167-3172

[4] Haemophilia Inhibitor Genetics Study - evaluation of a model for studies of complex diseases using linkage and association methods [J].

Berntorp, E ;

Astermark, J ;

Donfield, SM ;

Nelson, GW ;

Oldenburg, J ;

Shapiro, AD ;

Dimichele, DM ;

Ewenstein, BM ;

Gomperts, ED ;

Winkler, CA .

HAEMOPHILIA, 2005, 11 (04) :427-429

[5] CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis [J].

Braun, J ;

Donner, H ;

Siegmund, T ;

Walfish, PG ;

Usadel, KH ;

Badenhoop, K .

TISSUE ANTIGENS, 1998, 51 (05) :563-566

[6] An Mse I RFLP in the human CTLA4 promotor [J].

Deichmann, K ;

Heinzmann, A ;

Bruggenolte, E ;

Forster, J ;

Kuehr, J .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 225 (03) :817-818

[7]

Giscombe R, 2002, J RHEUMATOL, V29, P950

[8]

KEARNEY ER, 1995, J IMMUNOL, V155, P1032

[9] CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease [J].

Kouki, T ;

Sawai, P ;

Gardine, CA ;

Fisfalen, ME ;

Alegre, ML ;

DeGroot, LJ .

JOURNAL OF IMMUNOLOGY, 2000, 165 (11) :6606-6611

[10] The CTLA-4 gene is associated with multiple sclerosis [J].

Ligers, A ;

Xu, C ;

Saarinen, S ;

Hillert, J ;

Olerup, O .

JOURNAL OF NEUROIMMUNOLOGY, 1999, 97 (1-2) :182-190

← 1 2 →